Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03691532 · ClinicalTrials.gov registry record · NA

Postprandial Lipid Tracer and Exercise in Spinal Cord Injury

A NA study of Spinal Cord Injuries, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT03691532 is a NA study of Spinal Cord Injuries that has completed, run by University of Miami. The registered enrollment target is 18 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03691532, a NA study of Spinal Cord Injuries, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This study investigates the effect of upper extremity exercise on postprandial lipemia (PPL) in persons with spinal cord injury (SCI). Participants are measured at rest and fed a standardized meal following seated rest (CON) or arm cycling exercise (ACE). The meal is infused with "stable isotope lipid tracers" that allow for determination of the end fates of the fat in the meal.

Conditions Studied

Interventions

  • BEHAVIORAL Seated control (CON)
  • BEHAVIORAL Arm cycle exercise (ACE)
  • BEHAVIORAL Liquid meal

Study Locations (1)

Florida

  • Lois Pope Life Center - Miami

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2018-05-30
Est. Completion 2023-07-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03691532

The ClinicalTrials.gov registry entry for NCT03691532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Seated control (CON) is the first listed.

NCT03691532 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03691532 about?

NCT03691532 is a clinical study titled "Postprandial Lipid Tracer and Exercise in Spinal Cord Injury". This study investigates the effect of upper extremity exercise on postprandial lipemia (PPL) in persons with spinal cord injury (SCI). Participants are measured at rest and fed a standardized meal following seated rest (CON) or arm cycling exercise (ACE). The meal is infused with "stable isotope lip...

What is the current status of trial NCT03691532?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-05-30. Estimated completion is 2023-07-31.

What conditions does trial NCT03691532 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT03691532?

The interventions under investigation include: Seated control (CON) (BEHAVIORAL), Arm cycle exercise (ACE) (BEHAVIORAL), Liquid meal (BEHAVIORAL).

Who is sponsoring clinical trial NCT03691532?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03691532 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.